Data / New clinical trials / Finland
New clinical trials in Finland: 303 since Nov 2024
The full list. New clinical trials with a site in Finland: 303 rows for $15.15, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 11 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/country/finland, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
303 clinical studies with a site in Finland were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 114 have an industry sponsor and 229 are recruiting or about to. The newest, NCT07926321, was posted on November 9, 2026: A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without... (Boehringer Ingelheim).
The request: Every new clinical trial with a site in Finland, with the sponsor, phase, conditions and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 303New trials
- 114Industry sponsored
- 229Recruiting or not yet
- November 9, 2026Latest posted
Newest trials
The newest 100 of 303, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 9, 2026 | NCT07926321 | A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment | Boehringer Ingelheim | Phase 2 | Not yet recruiting | Idiopathic Pulmonary Fibrosis | 70 | Belgium, Finland, Germany, Japan, Mexico, South Korea, Spain, United States | clinicaltrials.gov |
| November 5, 2026 | NCT07920601 | Effects of C-Tactile-optimal Touch on Alcohol Craving and Relapse-Related Biomarkers in Alcohol Use Disorder | Aalto University | Not applicable | Completed | Alcohol Use Disorder | 21 | Finland | clinicaltrials.gov |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia... | clinicaltrials.gov |
| October 30, 2026 | NCT07906522 | Future School of Comprehensive Well-Being | University of Helsinki | Not applicable | Active not recruiting | Learning, Comprehensive Wellbeing, Social Wellbeing, Physical Wellbeing, Mental Wellbeing, Pedagogical Practices... | 1,440 | Finland | clinicaltrials.gov |
| October 28, 2026 | NCT07900620 | T1 Colorectal Cancer After Local Excision: Decision Between Surgery and Active Surveillance (T1LDA Trial) | Tampere University Hospital | Not applicable | Not yet recruiting | Colorectal Cancer | 500 | Finland | clinicaltrials.gov |
| October 27, 2026 | NCT07898774 | A Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant... | Swedish Orphan Biovitrum | Phase 3 | Recruiting | C3 Glomerulopathy (C3G), Primary Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN), Recurrent... | 30 | Brazil, Canada, Finland, France, Germany, Italy, Saudi Arabia, Spain... | clinicaltrials.gov |
| October 27, 2026 | NCT07897825 | FINtick - a Prospective Multicenter Study on Tick-borne Infections in Finland | Turku University Hospital | Observational | Recruiting | Tick Borne Encephalitis (TBE), Lyme Borreliosis, Neoehrlichiosis, Tick-Borne Diseases, Anaplasmosis, Babesiosis, Human... | 850 | Finland | clinicaltrials.gov |
| October 26, 2026 | NCT07893834 | Multimodal Stewardship Programme to Improve Antibiotic Prescribing for Children With Lower Respiratory Tract Infections | Tampere University | Not applicable | Not yet recruiting | Bronchitis, Acute, Community-acquired Pneumonia, Respiratory Tract Infections | 50,000 | Finland | clinicaltrials.gov |
| October 26, 2026 | NCT07893405 | Clinical Performance and Usability of the Heart Rate and Impedance Respiration Monitor Cable | GE Healthcare | Observational | Recruiting | Monitoring, ECG, Electrocardiogram | 50 | Finland | clinicaltrials.gov |
| October 20, 2026 | NCT07884019 | Stereotactic Body Radiotherapy (SBRT) Induced Pancreatic Atrophy for Prevention of Post Operative Pancreatic Fistulae (POPF) After... | Oulu University Hospital | Not applicable | Recruiting | Pancreatic Surgery, Prophylactic SBRT, Pancreatic Leak | 70 | Finland | clinicaltrials.gov |
| October 20, 2026 | NCT07882693 | The Effect of Bitewing Radiography on Outcomes and Costs of Treating Caries in Permanent Teeth | Jukka Leinonen | Not applicable | Not yet recruiting | Dental Caries, Teeth Loss, Necrosis of Pulp, Irreversible Pulpitis | 250 | Finland | clinicaltrials.gov |
| October 16, 2026 | NCT07878910 | Amoxicillin-clavulanate Versus Amoxicillin Versus Placebo in Acute Otitis Media in Children | Kuopio University Hospital | Phase 4 | Not yet recruiting | Acute Otitis Media, AOM - Acute Otitis Media | 219 | Finland | clinicaltrials.gov |
| October 16, 2026 | NCT07877454 | Preventing the Transition From Acute to Persistent Disabling Low Back Pain Through Cognitive Functional Therapy | University of Oulu | Not applicable | Not yet recruiting | Acute Low Back Pain (Low Back Pain for Less Than 3 Months) | 461 | Finland | clinicaltrials.gov |
| October 16, 2026 | NCT07877324 | Vascular Inflammation in Atherosclerosis - Whole Body Molecular PET/CT Imaging Using Folate Receptor β | Turku University Hospital | Not applicable | Recruiting | Atheroscleroses, Inflammation | 90 | Finland | clinicaltrials.gov |
| October 13, 2026 | NCT07871864 | Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse | Gustave Roussy, Cancer Campus, Grand Paris | Phase 3 | Recruiting | Osteosarcoma, Pediatric Osteosarcoma, Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults... | 530 | Denmark, Finland, France, Italy, Netherlands, Poland, Spain, Sweden | clinicaltrials.gov |
| October 9, 2026 | NCT07868146 | PREWELL Digital Well-being Promotion Intervention With the BitHabit App | University of Eastern Finland | Not applicable | Active not recruiting | General Mental Health and Well-Being, Mental Disorders, Common Mental Disorders (CMD) | 1,700 | Finland | clinicaltrials.gov |
| October 6, 2026 | NCT07860333 | Mobilisation After Endovascular Stroke Treatment | Karolinska Institutet | Observational | Recruiting | Stroke, Acute Ischemic Stroke, Acute Ischemic Stroke AIS, Endovascular Thrombectomy, Endovascular Treatments, Early... | 400 | Finland, Sweden | clinicaltrials.gov |
| October 1, 2026 | NCT07851441 | Prevalence of Pain During Cesarean Section | Women's Hospital HUS | Observational | Recruiting | Cesarean Birth | 200 | Finland | clinicaltrials.gov |
| September 30, 2026 | NCT07848607 | Night Work Hours Reduction Trial | Finnish Institute of Occupational Health | Not applicable | Not yet recruiting | Night Shift Work, Sickness Absence | 200 | Finland | clinicaltrials.gov |
| September 25, 2026 | NCT07842419 | Bizact Tonsillectomy: Postoperative Pain, Bleeding and Cost-effectiveness (Randomized Study) | Helsinki University Central Hospital | Not applicable | Completed | ENT Disease, Tonsil Disease, Surgery | 224 | Finland | clinicaltrials.gov |
| September 25, 2026 | NCT07840391 | Changes in Physical Activity, Sleep and Knee Function After Same-Day Discharge Knee Arthroplasty | Turku University Hospital | Observational | Recruiting | Arthrosis | 120 | Finland | clinicaltrials.gov |
| September 24, 2026 | NCT07838402 | Smart Sock Heart Rate Monitoring in Hospitalized Newborns | Tampere University Hospital | Observational | Enrolling by invitation | Healthy, Newborn Infant | 40 | Finland | clinicaltrials.gov |
| September 15, 2026 | NCT07820800 | NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP) | University of Eastern Finland | Not applicable | Recruiting | Type 2 Diabetes, Coronary Heart Disease, Myocardial Infarction, Cerebrovascular Disease, Stroke, Chronic Kidney... | 1,400 | Finland | clinicaltrials.gov |
| September 10, 2026 | NCT07814222 | A Prospective Diagnostic Trial of Al[¹⁸F]F-NOTA-folate PET in Patients With Suspected Cardiac Sarcoidosis and Infective Endocarditis | Turku University Hospital | Not applicable | Recruiting | Cardiac Sarcoidosis, Infective Endocarditis | 143 | Finland | clinicaltrials.gov |
| September 10, 2026 | NCT07812350 | Effectiveness and Cost-Effectiveness of a Digital Care Pathway and Asynchronous Communication for Patients With Hypertension | Wellbeing Services County of Pirkanmaa | Not applicable | Recruiting | Hypertension | 600 | Finland | clinicaltrials.gov |
| August 31, 2026 | NCT07795697 | Telerehabilitation After Spine Surgery | Kuopio University Hospital | Not applicable | Recruiting | Spine Surgery, Telerehabilitation, Low Back Pain | 300 | Finland | clinicaltrials.gov |
| August 27, 2026 | NCT07790458 | Automated Non-Invasive Blood Pressure Study | GE Healthcare | Observational | Recruiting | Blood Pressure, Blood Pressure Measurement | 50 | Finland | clinicaltrials.gov |
| August 25, 2026 | NCT07785141 | Spectroscopic Assessment of Myocardial Oxygenation Changes in Pediatric Heart Surgery | Spectrocor | Observational | Recruiting | Myocardial Ischemia, Heart Defects, Congenital, Reperfusion Injury, Myocardial | 30 | Finland | clinicaltrials.gov |
| August 21, 2026 | NCT07780019 | Microwave Ablation of Uterine Fibroids | Turku University Hospital | Observational | Active not recruiting | Uterine Fibroids (Leiomyoma) | 100 | Finland | clinicaltrials.gov |
| August 21, 2026 | NCT07778173 | Three-Dimensional Molds Based on Radiological imagEs in Patients With Cancer: the DIRECT Trial | Tampere University Hospital | Not applicable | Recruiting | Cancer, Tumor | 30 | Finland | clinicaltrials.gov |
| August 20, 2026 | NCT07775872 | Prospective Natural History Study of POLG Disease | The POLG Foundation | Observational | Recruiting | PolG, Primary Mitochondrial Myopathy | 300 | Australia, Denmark, Finland, Netherlands, Norway, Spain, Sweden, United... | clinicaltrials.gov |
| August 13, 2026 | NCT07763522 | Validation of a Methodology Using Isometric Dynamometer for Ankle STrength Assessment to Quantify LDH-induced Paresis | Helsinki University Central Hospital | Not applicable | Enrolling by invitation | Paresis, Lumbar Disc Herniation | 70 | Finland | clinicaltrials.gov |
| August 11, 2026 | NCT07757412 | Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple... | Odense University Hospital | Phase 2 | Not yet recruiting | Multiple Myeloma Progression | 50 | Denmark, Estonia, Finland, Norway | clinicaltrials.gov |
| August 10, 2026 | NCT07753993 | A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease. | AstraZeneca | Phase 3 | Recruiting | Chronic Kidney Disease | 7,000 | Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Czechia, Denmark... | clinicaltrials.gov |
| August 6, 2026 | NCT07750600 | AI-Assisted Clinical Documentation in Nurse-Led Telehealth Contacts | Hospital District of Helsinki and Uusimaa | Not applicable | Not yet recruiting | AI-assisted Documentation | 64 | Finland | clinicaltrials.gov |
| August 3, 2026 | NCT07742644 | A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to... | GlaxoSmithKline | Phase 3 | Not yet recruiting | Measles, Mumps, Rubella, Varicella (Chickenpox), Measles-Mumps-Rubella+Chickenpox Vaccine | 1,860 | Argentina, Finland, Italy, Puerto Rico, Taiwan, United States | clinicaltrials.gov |
| August 3, 2026 | NCT07742618 | Effectiveness of AI-Assisted Clinical Documentation | University of Turku | Not applicable | Not yet recruiting | Effectiveness of AI-assisted Clinical Documentation Tool, Healthy | 400 | Finland | clinicaltrials.gov |
| July 31, 2026 | NCT07740239 | A COhort Study on Factors Leading to Vulnerability in Adult Patients With Serious Medical cOnditionS: the COSMOS-I Trial | Tampere University Hospital | Observational | Recruiting | Pelvic Fracture, Prostate Cancer, Lung Cancer, Brain Metastasis, Chronic Subdural Hematoma | 2,050 | Finland | clinicaltrials.gov |
| July 31, 2026 | NCT07739667 | Blood Pressure Measurement Using Vitacam | Evondos Oy | Observational | Recruiting | Blood Pressure Measurement | 85 | Finland | clinicaltrials.gov |
| July 30, 2026 | NCT07738029 | OBE2026 - Effect of One Year Intensive Lifestyle Treatment in Children With ISO-BMI Over 30kg/m² and Their Families. | Tampere University Hospital | Not applicable | Recruiting | Obesity & Overweight | 20 | Finland | clinicaltrials.gov |
| July 23, 2026 | NCT07721766 | Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Training | Technical University of Munich | Not applicable | Recruiting | Healthy Volunteers, Muscle Hypertrophy, Glycolysis, Moderately Trainend | 120 | Finland, Germany, Ireland, Spain | clinicaltrials.gov |
| July 20, 2026 | NCT07712978 | Mothers' Heartbeat Intervention in Newborn's Phototherapy Treatment at Maternity Ward | Mervi Hakala | Not applicable | Completed | Anxiety, Stress, Experience | 40 | Finland | clinicaltrials.gov |
| July 13, 2026 | NCT07699640 | Minimally-invasive ICG-guided Retroperitoneal Sentinel Lymph Node Dissection in the Primary Staging of Testicular Cancer Versus Standard of... | Heinrich-Heine University, Duesseldorf | Not applicable | Not yet recruiting | Testicular Cancer, Testicular Germ Cell Tumor | 171 | Finland, Germany | clinicaltrials.gov |
| July 13, 2026 | NCT07697950 | NIBP Accuracy Study for Adult Subject Populations | GE Healthcare | Not applicable | Recruiting | Blood Pressure Measurement, Blood Pressure | 130 | Finland | clinicaltrials.gov |
| July 6, 2026 | NCT07684885 | NIBP Study for Neonate and Pediatric Subject Populations | GE Healthcare | Not applicable | Recruiting | Blood Pressure, Blood Pressure Measurement | 110 | Finland | clinicaltrials.gov |
| July 6, 2026 | NCT07684859 | NIBP Accuracy Study for Adult | GE Healthcare | Observational | Withdrawn | Blood Pressure, Blood Pressure Measurement | 0 | Finland | clinicaltrials.gov |
| July 1, 2026 | NCT07679633 | App-based Motor Skills Intervention in Primary School and Home Settings | Tampere University | Not applicable | Active not recruiting | Healthy, Motor Activity | 314 | Finland | clinicaltrials.gov |
| July 1, 2026 | NCT07678541 | Cholecystitis Outcomes in the Investigation of Cholecystectomy Versus EUS-GBD | Oulu University Hospital | Not applicable | Recruiting | Acute Cholecystitis | 116 | Finland | clinicaltrials.gov |
| June 30, 2026 | NCT07676227 | Pulse Oximetry Performance Test for PaMo - Controlled Desaturation Test | Tampere University | Not applicable | Completed | Vital Sign Monitoring, Vital Signs | 24 | Finland | clinicaltrials.gov |
| June 29, 2026 | NCT07672769 | Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes | Faron Pharmaceuticals Ltd | Phase 2 | Recruiting | Higher Risk Myelodysplastic Syndromes | 90 | Czechia, Finland, France, Italy, Poland, United Kingdom, United States | clinicaltrials.gov |
| June 24, 2026 | NCT07665320 | Impedance Plethysmography Based Deep Vein Thrombosis Monitoring During Catheter-directed Thrombolysis | Tampere University | Observational | Recruiting | Deep Vein Thrombosis (DVT) | 40 | Finland | clinicaltrials.gov |
| June 22, 2026 | NCT07660198 | Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents | Pfizer | Phase 3 | Recruiting | Pneumococcal Disease | 1,200 | Finland, Poland, Puerto Rico, United States | clinicaltrials.gov |
| June 17, 2026 | NCT07655037 | Execise Intervention in Adult Severe Asthma | Helsinki University Central Hospital | Not applicable | Recruiting | Severe Asthma, Asthma | 60 | Finland | clinicaltrials.gov |
| June 17, 2026 | NCT07653061 | Physical Activity Intervention for Older Family Carers | Tampere University | Not applicable | Not yet recruiting | Feasibility Studies, Physical Activity and Wellbeing | 50 | Finland | clinicaltrials.gov |
| June 12, 2026 | NCT07646340 | Long-term Pelvic Floor and Sexual Health After Obstetric Anal Sphincter Injury in Finland | Tampere University Hospital | Observational | Enrolling by invitation | Obstetric Anal Sphincter Injury, Sexual Dysfunction and the Mode of Deliveries, Pelvic Floor Disorders | 600 | Finland | clinicaltrials.gov |
| June 12, 2026 | NCT07646223 | Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis | Tampere University Hospital | Phase 2 | Not yet recruiting | Ulcerative Colitis (UC), Primary Sclerosing Cholangitis (PSC), Pediatric Inflammatory Bowel Diseases | 140 | Finland | clinicaltrials.gov |
| June 12, 2026 | NCT07644130 | Bergen Four-Day Treatment (B4DT) for Obsessive-Compulsive Disorder | Tampere University Hospital | Not applicable | Recruiting | Obsessive Compulsive Disorder (OCD) | 65 | Finland | clinicaltrials.gov |
| June 10, 2026 | NCT07640568 | Parent-led Assessment and Recognition of AOM Using Digital Ear Imaging | Turku University Hospital | Not applicable | Recruiting | Acute Otitis Media, Otitis Media | 40 | Finland | clinicaltrials.gov |
| June 10, 2026 | NCT07639164 | Stronger Together: Antenatal Depressive Symptoms - Prevalence and Digital Treatment | University of Turku | Not applicable | Not yet recruiting | Depression / Major Depressive Disorder, Antenatal Depression | 1,000 | Finland | clinicaltrials.gov |
| June 8, 2026 | NCT07634042 | Ionized Calcium and Bleeding in Cardiac Surgery | Helsinki University Central Hospital | Observational | Not yet recruiting | Cardiac Surgery Subjects | 4,300 | Finland | clinicaltrials.gov |
| June 5, 2026 | NCT07628296 | Non-Invasive Blood Pressure Accuracy Study for Adult Subject Populations | GE Healthcare | Not applicable | Recruiting | Blood Pressure, Blood Pressure Measurement | 130 | Finland | clinicaltrials.gov |
| June 4, 2026 | NCT07627386 | Family FINGER: Lifestyle Intervention Among Older Caregivers | Tarja Välimäki | Not applicable | Recruiting | Positive Mental Health | 100 | Finland | clinicaltrials.gov |
| May 29, 2026 | NCT07615205 | Strength for Caregiving | Susanna Kunvik | Not applicable | Not yet recruiting | Mental Well-being, Muscle Strengh, Dietary Habits, Quality of Life, Nutritional Status, Functional Capacity | 100 | Finland | clinicaltrials.gov |
| May 29, 2026 | NCT07614425 | Finnish Carpal Tunnel Surgery Study | Helsinki University Central Hospital | Not applicable | Recruiting | Carpal Tunnel Syndrome | 180 | Finland | clinicaltrials.gov |
| May 29, 2026 | NCT07613710 | A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy | H. Lundbeck A/S | Phase 1 | Recruiting | Narcolepsy | 104 | Finland | clinicaltrials.gov |
| May 28, 2026 | NCT07611110 | AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01) | AstraZeneca | Phase 3 | Recruiting | Metastatic Castration-resistant Prostate Cancer | 670 | Australia, Austria, Belgium, Brazil, Canada, China, Finland, France, Germany... | clinicaltrials.gov |
| May 27, 2026 | NCT07608341 | Influence of Probiotics on Early Gut Microbial Colonization | BioGaia AB | Not applicable | Not yet recruiting | C-Section | 150 | Finland | clinicaltrials.gov |
| May 27, 2026 | NCT07607925 | A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL | GlaxoSmithKline | Phase 1/2 | Recruiting | Lymphoma, Non-Hodgkin | 49 | Australia, Canada, Finland, France, Italy, Japan, Spain, United States | clinicaltrials.gov |
| May 22, 2026 | NCT07604740 | The Effectiveness of Couple Therapy and Relationship Support | University of Helsinki | Not applicable | Enrolling by invitation | Healthy Adult | 400 | Finland | clinicaltrials.gov |
| May 20, 2026 | NCT07600463 | UVC in Prevention of Surgical Wound Infection | Ville Leinonen | Not applicable | Not yet recruiting | Hydrocephalus | 75 | Finland | clinicaltrials.gov |
| May 18, 2026 | NCT07594327 | Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer | Tampere University Hospital | Observational | Enrolling by invitation | Cervical Cancers, Vaginal Cancers, Vulvar Cancers, Endometrial Cancer, Gynecologic Cancers | 21 | Finland | clinicaltrials.gov |
| May 15, 2026 | NCT07589803 | The Aim of This Study is to Assess the Feasibility of the Study Protocol and the Acceptability of the Mobile Application-Based... | Coxa, Hospital for Joint Replacement | Not applicable | Not yet recruiting | Feasibility Studies | 40 | Finland | clinicaltrials.gov |
| May 14, 2026 | NCT07587424 | Impact of Dietary Fibre Supplementation on Gut Symptoms in Healthy Participants | University of Helsinki | Not applicable | Not yet recruiting | Gastrointestinal Symptoms | 28 | Finland | clinicaltrials.gov |
| May 13, 2026 | NCT07585266 | A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable... | GlaxoSmithKline | Phase 3 | Recruiting | Gastrointestinal Stromal Neoplasms | 800 | Argentina, Australia, Brazil, Canada, China, Finland, France, Greece, Italy... | clinicaltrials.gov |
| May 13, 2026 | NCT07582549 | Finnish Children´s Protracted Cough | Tampere University Hospital | Phase 3 | Recruiting | Chronic Cough | 100 | Finland | clinicaltrials.gov |
| May 12, 2026 | NCT07580170 | Randomized Clinical Trial for Tonsil Surgery in Adults With Obstructive Sleep Apnea and Enlarged Tonsils | Turku University Hospital | Not applicable | Not yet recruiting | Sleep Apnea, Obstructives, Tonsil Hypertrophy | 132 | Finland | clinicaltrials.gov |
| May 12, 2026 | NCT07579390 | Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE) | Helsinki University Central Hospital | Not applicable | Active not recruiting | Acute Kidney Failure, Renal Replacement Therapy for Acute Kidney Injury in ICU, Sedation in Intensive Care Unit... | 3,500 | Australia, Belgium, Estonia, Finland, Germany, Italy, Luxembourg, New Zealand... | clinicaltrials.gov |
| May 8, 2026 | NCT07575009 | Continuous Antibiotic Infusion In Children | Tampere University Hospital | Phase 3 | Recruiting | Infection | 150 | Finland | clinicaltrials.gov |
| May 7, 2026 | NCT07573462 | A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants | Pfizer | Phase 3 | Recruiting | Pneumococcal Disease | 2,400 | Argentina, Australia, Canada, Finland, Germany, Greece, Hungary, Italy, Poland... | clinicaltrials.gov |
| May 5, 2026 | NCT07567105 | Stability of Orthodontic Treatment of Anterior Open-bite | University of Helsinki | Observational | Recruiting | Open Bite | 80 | Finland | clinicaltrials.gov |
| May 5, 2026 | NCT07566949 | The Finnish Uterine Prolapse Surgery Trial (The Fin-UP Trial) | Tampere University Hospital | Not applicable | Recruiting | Uterine Prolapse, Pelvic Organ Prolapse Vaginal Surgery, Pelvic Organ Prolapse (POP) | 426 | Finland | clinicaltrials.gov |
| May 4, 2026 | NCT07564141 | Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based... | Genmab | Phase 3 | Recruiting | Platinum-Sensitive Ovarian Cancer, Ovarian Cancer | 688 | Finland, Japan, United States | clinicaltrials.gov |
| May 4, 2026 | NCT07563738 | A 2-part Phase 1/2 Open-label Trial on ODM-212 | Orion Corporation, Orion Pharma | Phase 1/2 | Recruiting | Mesothelioma, Pancreatic Cancer, NSCLC (Advanced Non-small Cell Lung Cancer) | 229 | Denmark, Finland, France, Spain, Switzerland, United Kingdom, United States | clinicaltrials.gov |
| April 29, 2026 | NCT07556328 | Histomolecular Profiling in Small-Bowel Diseases | Tampere University Hospital | Observational | Recruiting | Celiac Disease, Small Bowel Disease, Refractory Celiac Disease | 300 | Finland | clinicaltrials.gov |
| April 27, 2026 | NCT07552935 | Management of Dyspnea With High- Flow Nasal Therapy | Tampere University Hospital | Not applicable | Recruiting | Palliative Care, Breathlessness | 40 | Finland | clinicaltrials.gov |
| April 22, 2026 | NCT07546500 | A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian... | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | Phase 3 | Recruiting | Ovarian Cancer | 420 | Argentina, Australia, Belgium, Brazil, Canada, Croatia, Denmark, Estonia... | clinicaltrials.gov |
| April 22, 2026 | NCT07544654 | DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and... | Boehringer Ingelheim | Phase 3 | Recruiting | Extrapulmonary Neuroendocrine Cancer (epNEC) | 390 | Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia... | clinicaltrials.gov |
| April 21, 2026 | NCT07540988 | FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression | Boehringer Ingelheim | Phase 3 | Recruiting | Interstitial Lung Diseases | 466 | Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Finland, France... | clinicaltrials.gov |
| April 16, 2026 | NCT07535112 | A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has... | Bayer | Phase 1 | Recruiting | Advanced/Metastatic Colorectal Adenocarcinoma | 130 | Australia, Belgium, Denmark, Finland, Italy, Netherlands, Singapore, Spain... | clinicaltrials.gov |
| April 14, 2026 | NCT07528833 | Health Effects of Mindfulness Based Stress Reduction Course in Treatment of Back Pain | Tampere University Hospital | Not applicable | Recruiting | Back Pain | 120 | Finland | clinicaltrials.gov |
| April 13, 2026 | NCT07522073 | A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal... | Incyte Corporation | Phase 3 | Recruiting | Solid Tumors | 588 | Australia, Austria, Belgium, Canada, Denmark, Finland, France, Georgia... | clinicaltrials.gov |
| March 31, 2026 | NCT07502560 | A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or... | GlaxoSmithKline | Phase 4 | Recruiting | Herpes Zoster | 33,609 | Finland | clinicaltrials.gov |
| March 30, 2026 | NCT07500922 | Menopause Effects on Cortico-reticular Functioning | University of Jyvaskyla | Not applicable | Recruiting | Menopause, Hormone Replacement Therapy | 20 | Finland | clinicaltrials.gov |
| March 27, 2026 | NCT07497087 | A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis | Boehringer Ingelheim | Phase 3 | Recruiting | Systemic Sclerosis | 448 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China... | clinicaltrials.gov |
| March 25, 2026 | NCT07492979 | Conduction System Pacing vs. Biventricular Pacing for Cardiac Resynchronization Therapy | Copenhagen University Hospital, Rigshospitalet | Not applicable | Recruiting | Cardiac Resynchronisation Therapy (CRT), Heart Failure, Conduction System Pacing | 1,100 | Denmark, Finland, Norway, Sweden | clinicaltrials.gov |
| March 19, 2026 | NCT07484100 | Efficacy of Proximal Median Nerve Release | Tampere University Hospital | Not applicable | Not yet recruiting | Carpal Tunnel Surgery, Median Nerve Compression, Median Nerve Entrapment | 160 | Finland | clinicaltrials.gov |
| March 17, 2026 | NCT07476729 | International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) | Charite University, Berlin, Germany | Phase 3 | Recruiting | B-Cell Acute Lymphoblastic Leukaemia | 750 | Austria, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Israel... | clinicaltrials.gov |
| March 16, 2026 | NCT07473947 | Performance and Safety Follow-up of Bioabsorbable Headless Inion CompressOnTM Screws in the Fixation of Bone Fractures in Ankle, Knee and... | Inion Oy | Not applicable | Recruiting | Ankle Fractures, Knee Fractures, Elbow Fractures | 80 | Finland | clinicaltrials.gov |
| March 16, 2026 | NCT07473596 | Predictors and Long-term Incidence of In-stent Restenosis After Chronic Total Occlusion Percutaneous Coronary Intervention | Lauri Mansikkaniemi | Not applicable | Completed | Coronary Artery Disease (CAD), Chronic Total Occlusion of Coronary Artery, Chronic Total Occlusion (CTO) | 294 | Finland | clinicaltrials.gov |
| March 16, 2026 | NCT07472517 | DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and... | Boehringer Ingelheim | Phase 3 | Recruiting | Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC) | 670 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China... | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Tampere University Hospital | 26 | October 28, 2026 |
| Helsinki University Central Hospital | 26 | September 25, 2026 |
| Turku University Hospital | 22 | October 27, 2026 |
| Boehringer Ingelheim | 10 | November 9, 2026 |
| GlaxoSmithKline | 10 | August 3, 2026 |
| University of Turku | 10 | August 3, 2026 |
| University of Helsinki | 9 | October 30, 2026 |
| GE Healthcare | 9 | October 26, 2026 |
| Kuopio University Hospital | 9 | October 16, 2026 |
| Merck Sharp & Dohme LLC | 9 | February 12, 2026 |
| Oulu University Hospital | 7 | October 20, 2026 |
| Pfizer | 7 | June 22, 2026 |
| Tampere University | 6 | October 26, 2026 |
| University of Eastern Finland | 6 | October 9, 2026 |
| AstraZeneca | 6 | August 10, 2026 |
| Bayer | 6 | April 16, 2026 |
| University of Oulu | 5 | October 16, 2026 |
| Bristol-Myers Squibb | 4 | March 2, 2026 |
| Sanofi | 4 | February 17, 2026 |
| Aalto University | 3 | November 5, 2026 |
Conditions
| Condition group | New trials | Latest |
|---|---|---|
| Depression | 10 | October 30, 2026 |
| Obesity | 10 | July 30, 2026 |
| Overweight | 8 | July 30, 2026 |
| Neoplasms | 7 | August 21, 2026 |
| Prostatic Neoplasms | 7 | July 31, 2026 |
| Anxiety Disorders | 6 | October 30, 2026 |
| Stroke | 6 | October 6, 2026 |
| Recurrence | 6 | May 27, 2026 |
| Endometrial Neoplasms | 6 | May 18, 2026 |
| Heart Failure | 6 | March 25, 2026 |
| Breast Neoplasms | 6 | July 14, 2025 |
| Mental Disorders | 5 | October 30, 2026 |
| Motor Activity | 5 | September 25, 2026 |
| Depressive Disorder, Major | 5 | June 10, 2026 |
| Ovarian Neoplasms | 5 | May 4, 2026 |
| Diabetes Mellitus, Type 1 | 5 | February 20, 2026 |
| Parkinson Disease 4, Autosomal Dominant Lewy Body | 5 | November 28, 2025 |
| Disease | 4 | October 20, 2026 |
| Coronary Artery Disease | 4 | October 16, 2026 |
| Diabetes Mellitus, Type 2 | 4 | September 15, 2026 |
| Atrial Fibrillation | 4 | February 24, 2026 |
| Neoplasm Metastasis | 4 | December 3, 2025 |
| Colonic Neoplasms | 3 | October 28, 2026 |
| Psychological Well-Being | 3 | October 9, 2026 |
| Health Behavior | 3 | October 9, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Not applicable | 135 | November 5, 2026 |
| Phase 3 | 76 | November 4, 2026 |
| Observational | 54 | October 27, 2026 |
| Phase 2 | 12 | November 9, 2026 |
| Phase 1 | 10 | May 29, 2026 |
| Phase 1/2 | 7 | May 27, 2026 |
| Phase 2/3 | 6 | February 17, 2026 |
| Phase 4 | 3 | October 16, 2026 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.